Yorkton Equity Group Inc. (TSXV:YEG)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	19	23	17	17	20	17
Market Cap Growth	20.59%	33.33%	0.00%	-16.59%	18.48%	-
Enterprise Value	119	122	93	50	39	24
Last Close Price	0.17	0.20	0.15	0.15	0.18	0.25
PE Ratio	2.83	3.43	4.92	-	-	-
PS Ratio	3.26	3.90	3.95	4.94	10.96	18.49
PB Ratio	0.60	0.71	0.68	0.81	0.99	1.58
P/OCF Ratio	3.76	4.67	4.66	21.64	-	-
EV/Sales Ratio	20.24	21.20	21.65	14.63	20.95	25.58
EV/EBITDA Ratio	23.95	25.69	26.99	51.24	-	160.82
EV/EBIT Ratio	24.04	25.79	27.03	51.42	-	162.62
Debt / Equity Ratio	3.19	3.17	4.01	1.70	1.15	0.24
Debt / EBITDA Ratio	20.44	21.02	29.22	36.46	-	17.88
Asset Turnover	0.04	0.04	0.05	0.07	0.06	0.06
Quick Ratio	0.35	0.19	0.27	0.73	0.16	0.45
Current Ratio	0.54	0.37	0.43	0.83	0.21	0.50
Return on Equity (ROE)	23.83%	23.17%	14.95%	-0.78%	-8.01%	-5.26%
Return on Assets (ROA)	2.31%	2.23%	2.28%	1.17%	-0.35%	0.62%
Return on Capital (ROIC)	2.39%	2.31%	2.36%	1.21%	-0.37%	0.72%
Earnings Yield	35.39%	29.14%	20.34%	-0.96%	-6.20%	-2.47%
Buyback Yield / Dilution	0.02%	0.02%	-0.06%	-15.72%	-139.36%	-10.32%

Updated Nov 20, 2024. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.